2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92547°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
Á×À̾߱â, â¾÷ÀÚ±Ý 1000¸¸¿ø 2Â÷ ¹«»ó Áö¿ø ÁøÇà (2020-06-02)
¡®³ë¸Ó´Ï ³ë¾ÆÆ®¡¯ ¾ÆÆ® Å¥·¹ÀÌÅÍ ¸ð´ÏÄ« (2023-04-10)
´õÀ§, ÇÇÇÒ ¼ö ¾øÀ¸¸é Áñ°Ü¶ó! (2014-06-23)
BiKi, ÄÚÀÎ ¾÷°èÀÇ ³ª½º´Ú µÇ±â (2020-01-15)
SKÅÚ·¹ÄÞ, ¼­¿ï ÁöÇÏö¿¡ LTE-R ±¸Ãà (2018-03-26)
±èÇý¿ø ÀÚÀÛ°î ¶óÀÌºê ÆÛÆ÷¸Õ½º ¡®È¸»ö µµ½Ã¡¯ (2020-07-24)
º½³ªµéÀÌ ¾È¼º¸ÂÃã ÈÞ´ë¿ë ½ºÇÇÄ¿ SV927 (2013-05-02)
Citi Global Wealth Investments Issues Mid-Year Outlook 2022:... (2022-06-10)
ºñÅõºñ ¼­Àº±¤, À¥Å÷ µµ±¼¿Õ OST ¡®³Ê¸¦ ¶°³ª¡¯ (2021-02-26)
±º»ê½Ã, ¿¹¼ú¡¤ÄÜÅÙÃ÷ ½ºÅ×ÀÌ¼Ç Ã¢¾÷ ¾ÆÀ̵ð¾î °ø¸ð (2019-06-03)
½ÅÇÑÄ«µå, ¡®Ä«Ä«¿À¹ðÅ© ½ÅÇÑÄ«µå¡¯ Ãâ½Ã (2020-04-28)
Çѱ¹Áö¹æÇàÁ¤¿¬±¸¿ø, ¸ÞŸ¹ö½º Ȱ¿ë ¾÷¹«Çõ½Å (2022-02-17)
Çö´ëÂ÷±×·ì, ½º¸¶Æ®½ÃƼ ºñÀü ¹ßÇ¥ (2022-08-01)
»ï¼ºÀüÀÚ-¾ÆÁÖ´ë, Àΰø ±ÙÀ° ±¸µ¿±â ¿¬±¸ (2022-08-01)
¸®µå½ºÇÇÄ¿ÄÚ¸®¾Æ, Ä¿½ºÅÒ º¸À̽º À§ÇÑ º¸À̽º·¦ (2020-06-19)
ÇÇÄÚ-¿þÀ̺ê, ¹öÃß¾ó Äܼ­Æ® ½Ã¸®Áî Ãâ½Ã (2023-01-13)
¡®½Ã¼¼À̵µ ¹ÂÁ È«ÀºÈñ, ¿©¹è¿ìÀÇ µÎ ¾ó±¼?! (2015-06-22)
Áö¿ªÇù¾÷ û¼Ò³â ½Ã¹Î°¨¼ö¼º Çâ»ó ±³À° °³¹ß¡¤¿î¿µ (2022-08-27)
2021³â ´©Àû °¡ÀÔÀÚ ¼ö 100¸¸ ¸í µ¹ÆÄ (2021-10-27)
³» ÀÛǰÀÌ À¥Å÷ Ç÷§Æû¿¡ ¿¬ÀçµÈ´Ù (2021-10-27)
LG»ýȰ°Ç°­, ¾÷¹« ·Îº¿ ¡®¾Ë ÆÄÆ®À塯 ä¿ë (2020-02-27)
°­¿øµµ Àç³­ À̰ܳ»´Â °Ç°­ÇÑ ½£ Ä·ÆäÀÎ (2022-04-10)
ÆùŸ³ª, Àü±¹ À̸¶Æ® 83°³ ÁöÁ¡ ÄíŷŬ·¡½º ÁøÇà (2019-11-06)
ÀÎõ ¼öµµ±Ç¸Å¸³Áö µå¸²ÆÄÅ© ±¹È­ÃàÁ¦ (2013-09-17)
ÀüÅ뿹¼ú º¹¿ø ¹× ÀçÇö ¡®ÀÚÀ¯ °úÁ¦¡¯ °ø¸ð (2020-04-19)
       [ÀÌÀü][1]....[2673][2674][2675][2676][2677][2678][2679][2680][2681]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..